Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Accounts Payables (2016 - 2026)

Champions Oncology has reported Accounts Payables over the past 16 years, most recently at $5.7 million for Q1 2026.

  • Quarterly results put Accounts Payables at $5.7 million for Q1 2026, up 12.43% from a year ago — trailing twelve months through Jan 2026 was $5.7 million (up 12.43% YoY), and the annual figure for FY2025 was $4.2 million, down 26.76%.
  • Accounts Payables for Q1 2026 was $5.7 million at Champions Oncology, down from $6.0 million in the prior quarter.
  • Over the last five years, Accounts Payables for CSBR hit a ceiling of $6.0 million in Q4 2025 and a floor of $2.5 million in Q3 2022.
  • Median Accounts Payables over the past 5 years was $4.8 million (2025), compared with a mean of $4.7 million.
  • Biggest five-year swings in Accounts Payables: surged 127.0% in 2023 and later dropped 26.76% in 2025.
  • Champions Oncology's Accounts Payables stood at $4.6 million in 2022, then dropped by 1.5% to $4.5 million in 2023, then rose by 7.01% to $4.9 million in 2024, then grew by 23.47% to $6.0 million in 2025, then fell by 4.46% to $5.7 million in 2026.
  • The last three reported values for Accounts Payables were $5.7 million (Q1 2026), $6.0 million (Q4 2025), and $4.8 million (Q3 2025) per Business Quant data.